BSEResult5d ago · 14 Aug 2026, 06:28 pm

AS PER ATTACHED

Centenial Surgical Suture Ltd · 531380

✦ AI SummaryResults

Centenial Surgical Suture Ltd has approved its standalone un-audited financial results for the quarter ended June 30, 2026, and submitted the documents to BSE Limited.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk2/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Centenial Surgical Suture Ltd - 531380 - Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026

Attachments (1)

📄

fd3cff27-9bf2-44f7-b63b-19050650d7d4.pdf

pdf

Download →

View document text

CENTENIAL SU 1, C, ( At S •j TUR E LT [J Friday,Augustl4,2026 Department of Corporate Service ·· BSE Limited, Registered Office : Floor 25, P. J. Towers, Dalal Street, Fort, Mumbai 400001. MAHARASHTRA. T: 2272 1233 I 1234 I F: 2272 3121 I 3719 I www.bseindia.com Subject : Approval of Standalone Un-Audited Financial Results for the quarter ended June 30, 2026. Reference: CENTENIAL SURGICAL SUTURE LTD. Scrip Code: 531380 Dear Sir, In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Un-Audited Financial Results for the quarter ended June 30, 2026. 2). Limited Review Report for the quarter ended June 30, 2026. You are requested to kindly take the same on your record. • The meeting commenced at 5.00 p.m. & concluded at 5.30 p.m. Sincerely, NIAL SURGICAL SU URE LTD. Vijay MAJREKAR Director & Chief Executive Officer DIN: 00804808 Enclosures: as mentioned above.